K S Gilmore1, C McLintock1. 1. National Women's Health, Auckland City Hospital, New Zealand.
Abstract
OBJECTIVE: We reviewed outcomes of 52 pregnancies in 45 women with immune thrombocytopenic purpura who delivered at Auckland Hospital with an antenatal platelet count of <100 × 109/L. OUTCOME MEASURES: Primary outcomes were maternal platelet count at delivery and treatment response. Secondary outcomes included post-partum haemorrhage (PPH). RESULTS: Most women had thrombocytopenia at delivery. Treatment with prednisone was given in 14 (27%) pregnancies with responses considered safe for delivery in 11 pregnancies (79%). Women in eight pregnancies also received intravenous immunoglobulin; in five pregnancies (63%) a platelet response acceptable for delivery was achieved.Seventeen pregnancies (33%) were complicated by a PPH ≥500 mL. Ten pregnancies (19%) were complicated by a PPH ≥1000 mL. PPH was reported in all women with a platelet count <50 × 109/L at delivery. CONCLUSIONS: There were no antenatal bleeding complications but PPH was common among women with platelet counts <50 × 109/L at the time of birth.
OBJECTIVE: We reviewed outcomes of 52 pregnancies in 45 women with immune thrombocytopenic purpura who delivered at Auckland Hospital with an antenatal platelet count of <100 × 109/L. OUTCOME MEASURES: Primary outcomes were maternal platelet count at delivery and treatment response. Secondary outcomes included post-partum haemorrhage (PPH). RESULTS: Most women had thrombocytopenia at delivery. Treatment with prednisone was given in 14 (27%) pregnancies with responses considered safe for delivery in 11 pregnancies (79%). Women in eight pregnancies also received intravenous immunoglobulin; in five pregnancies (63%) a platelet response acceptable for delivery was achieved.Seventeen pregnancies (33%) were complicated by a PPH ≥500 mL. Ten pregnancies (19%) were complicated by a PPH ≥1000 mL. PPH was reported in all women with a platelet count <50 × 109/L at delivery. CONCLUSIONS: There were no antenatal bleeding complications but PPH was common among women with platelet counts <50 × 109/L at the time of birth.
Authors: Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George Journal: Blood Date: 2008-11-12 Impact factor: 22.113
Authors: Dongmei Sun; Nadine Shehata; Xiang Y Ye; Sandra Gregorovich; Bryon De France; Donald M Arnold; Prakesh S Shah; Ann Kinga Malinowski Journal: Blood Date: 2016-07-11 Impact factor: 22.113
Authors: Diego F Wyszynski; Wendy J Carman; Alan B Cantor; John M Graham; Liza H Kunz; Anne M Slavotinek; Russell S Kirby; John Seeger Journal: J Pregnancy Date: 2016-03-22
Authors: Sara Arcudi; Alice Ronchi; Marco Capecchi; Enrico Iurlaro; Manuela W Ossola; Ilaria Mancini; Gabriella Schivardi; Anna Maria Marconi; Gian Marco Podda; Andrea Artoni Journal: Br J Haematol Date: 2022-03-10 Impact factor: 8.615